Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C P Cross

Showing results (101-110 of 221) with videos related to

Pageof 23
Sort By:
The Hematology Journal : the Official Journal of the European Haematology Association|December 1, 2004
Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further casesJosé L Vizmanos, Roberto Hernández, María J Vidal, et al.
British Journal of Haematology|July 21, 2005
Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasiaDavid Dingli, Francis H Grand, Victor Mahaffey, et al.
Haematologica|February 14, 2007
Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta geneChristoph Walz, Georgia Metzgeroth, Claudia Haferlach, et al.
Leukemia|November 18, 2025
Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genesMatthew Salmon, Nicole Naumann, Jenny Rinke, et al.
Leukemia|July 15, 2023
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohortGeorgia Metzgeroth, Laurenz Steiner, Nicole Naumann, et al.
Blood|November 5, 2011
Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasmsJoannah Score, Claire Hidalgo-Curtis, Amy V Jones, et al.
British Journal of Haematology|July 30, 2013
Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progressionMarta Fernandez-Mercado, Andrea Pellagatti, Cristina Di Genua, et al.
Blood|February 2, 2006
Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapyJaspal Kaeda, Derville O'Shea, Richard M Szydlo, et al.
Haematologica|May 21, 2009
Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single caseLaura Chiecchio, Gian Paolo Dagrada, Rebecca K M Protheroe, et al.
Plos One|February 6, 2014
Megalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutationsWilliam J Tapper, Nicola Foulds, Nicholas C P Cross, et al.
Pageof 23

Showing results (101-110 of 221) with videos related to

Sort By:
Pageof 23
The Hematology Journal : the Official Journal of the European Haematology Association|December 1, 2004
Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further casesJosé L Vizmanos, Roberto Hernández, María J Vidal, et al.
British Journal of Haematology|July 21, 2005
Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasiaDavid Dingli, Francis H Grand, Victor Mahaffey, et al.
Haematologica|February 14, 2007
Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta geneChristoph Walz, Georgia Metzgeroth, Claudia Haferlach, et al.
Leukemia|November 18, 2025
Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genesMatthew Salmon, Nicole Naumann, Jenny Rinke, et al.
Leukemia|July 15, 2023
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohortGeorgia Metzgeroth, Laurenz Steiner, Nicole Naumann, et al.
Blood|November 5, 2011
Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasmsJoannah Score, Claire Hidalgo-Curtis, Amy V Jones, et al.
British Journal of Haematology|July 30, 2013
Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progressionMarta Fernandez-Mercado, Andrea Pellagatti, Cristina Di Genua, et al.
Blood|February 2, 2006
Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapyJaspal Kaeda, Derville O'Shea, Richard M Szydlo, et al.
Haematologica|May 21, 2009
Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single caseLaura Chiecchio, Gian Paolo Dagrada, Rebecca K M Protheroe, et al.
Plos One|February 6, 2014
Megalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutationsWilliam J Tapper, Nicola Foulds, Nicholas C P Cross, et al.
Pageof 23